Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.
The Atellica DCA Analyzer uses the same robust latex agglutination inhibition immunoassay as the DCA Vantage and DCA 2000+ analyzers.
Small sample size reduces patient discomfort and likelihood of operator error.
Enables extended sample hold time, mitigates risk of lost samples and need to retest patients.
Atellica® DCA HbA1c test can process hemolyzed samples and helps reduce pre-analytical errors caused by specimen collection.
Unlike other methodologies, Siemens Healthineers immunoassay test was specifically designed to target only HbA1c.
Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.